Go Symbol Lookup
Loading...

Arena Pharmaceuticals Inc

More

  • *Novo shares up 0.7 percent, outperforming sector. COPENHAGEN, May 24- Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential.

  • NEW YORK, May 9- Three long-time favorites of the short-selling crowd are making those investors eat crow, as Tesla, Barnes& Noble and Green Mountain Coffee are racking up big gains, making an already painful year for contrarian investors even worse. Barnes& Noble shares rose 24 percent on reports of a possible acquisition of some of its assets by Microsoft.

  • European regulators reject Vivus diet pill again Thursday, 21 Feb 2013 | 5:41 PM ET

    Feb 21- European health regulators for a second time rejected a diet pill developed by Vivus Inc and said the obesity treatment would not be approved there unless the company conducts a large lengthy trial to prove its heart safety, Vivus said on Thursday.

  • FACTBOX-Diet pills' weighty safety issues Thursday, 7 Feb 2013 | 12:06 AM ET

    It was sold legally before the U.S. Food and Drug Administration gained the power to regulate drugs in 1938.. It was widely used to treat weight-loss during World War Two and afterwards, but was eventually banned as an obesity medication by the FDA in 1979..

  • Lightning Round: DuPont, Phillips 66 & More Tuesday, 5 Feb 2013 | 6:36 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Jan 22- Arena Pharmaceuticals Inc said the European health regulator had raised concerns with the company's obesity drug, Belviq, sending its shares down as much as 10 percent.

  • 13 Biotech Stock Predictions for 2013 Wednesday, 2 Jan 2013 | 7:55 AM ET

    TheStreet.com offers up 13 biotech predictions for 2013.

  • Big Pharma Bets on Obesity Drug Binge Thursday, 27 Dec 2012 | 2:18 AM ET

    As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry's appetite has been whetted for a fresh surge in business.

  • How to Profit From Alexza Pharma FDA Ruling Wednesday, 19 Dec 2012 | 12:29 PM ET

    Here's how to profit from the coming Alexza FDA run down.

Most Popular Video

Tuesday, 18 Jun 2013 | 7:10 AM ET

An airline passenger records a Chinese cargo handler as he tosses boxes of something on to and off of a conveyor belt for shipment. Hopefully, the cargo was packed well.

Tuesday, 18 Jun 2013 | 9:33 AM ET

Plans to take PC maker Dell private by leveraging the company's balance sheet are misguided, CNBC's Jim Cramer said on "Squawk on the Street" Tuesday, because the company is facing lower margins and an increased competition from rival Hewlett Packard.

Tuesday, 18 Jun 2013 | 12:47 PM ET

Supply shortages and rising rates are positive for the real estate market, Colony Capital CEO Tom Barrack says.